Skip to search formSkip to main contentSkip to account menu

maropitant citrate

Known as: (2S,3S)-N-(5-(1,1-Dimethylethyl)-2-methoxybenzyl)-2-(diphenylmethyl)-1-azabicyclo(2.2.2)octan-3-amine 2-hydroxy-1,2,3-propanetricarboxylate (1:1), Monohydrate, 2-benzhydryl-N-(5-tert-butyl-2-methoxybenzyl)quinuclidin-3-amine citrate monohydrate 
A neurokinin receptor antagonist with antiemetic activity. This agent is approved for veterinary use only.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
BackgroundNausea is a subjective sensation which is difficult to measure in non-verbal species. The aims of this study were to… 
Review
2017
Review
2017
Neurokinin-1 (NK-1) receptors are present in both the central nervous system and peripheral tissues. Substance P (SP) is the… 
2014
2014
OBJECTIVE To evaluate effects of maropitant, acepromazine, and electroacupuncture on morphine-related signs of nausea and… 
2014
2014
Background Vomiting is a common complication associated with the use of hydromorphine for pre‐emptive analgesia in dogs. The… 
2014
2014
OBJECTIVES To assess the prevalence of gastrointestinal toxicity in dogs receiving chemotherapy with vincristine and… 
2014
2014
  • B. H. Hay Kraus
  • Journal of the American Veterinary Medical…
  • 2014
  • Corpus ID: 36036615
OBJECTIVE To evaluate the effectiveness of orally administered maropitant citrate in preventing vomiting after hydromorphone… 
2013
2013
The pharmacokinetics of maropitant were evaluated in beagle dogs dosed orally with Cerenia® tablets (Pfizer Animal Health) once… 
2011
2011
Murine ulcerative dermatitis (UD) is a common progressive condition of mice with a C57BL/6 background. Typically, mice present… 
Review
2010
Review
2010
Importance of the field: Substance P is involved in mediating a number of biological effects such as emesis, pain, inflammation…